Association between soluble interleukin-2 receptor levels and disease severity in Complex Regional Pain Syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22217

Enrollment

Registered

2018-09-10

Start date

2018-10-08

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regional Pain Syndrome Pathophysiology Complex Regionaal Pijnsyndroom

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - The subject meets the new IASP clinical diagnostic criteria for CRPS (=diagnosis CRPS). - Age ≥ 18 years. - Only one limb is affected.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - History of an auto-inflammatory or autoimmune disease. - Current treatment with immunomodulating medication or treatment within the last 6 months. - Ill in the past two weeks or at the time of the visit. - Knowledge of or confirmed pregnancy.

Design outcomes

Primary

Measure	Time frame
sIL-2R CRPS severity score as described in Harden, 2017	—

Contacts

Public ContactK.D. Bharwani

bharwani.kd@gmail.com

Outcome results